College of Osteopathic Medicine, Edison Biotechnology Institute, Department of Chemistry and Biochemistry, The Molecular and Cellular Biology Program, Department of Biological Science and Department of Biomedical Science, Ohio University, USA.
Evid Based Complement Alternat Med. 2007 Dec;4(4):401-7. doi: 10.1093/ecam/nem013.
The leaves of Lagerstroemia speciosa (Lythraceae), a Southeast Asian tree more commonly known as banaba, have been traditionally consumed in various forms by Philippinos for treatment of diabetes and kidney related diseases. In the 1990s, the popularity of this herbal medicine began to attract the attention of scientists worldwide. Since then, researchers have conducted numerous in vitro and in vivo studies that consistently confirmed the antidiabetic activity of banaba. Scientists have identified different components of banaba to be responsible for its activity. Using tumor cells as a cell model, corosolic acid was isolated from the methanol extract of banaba and shown to be an active compound. More recently, a different cell model and the focus on the water soluble fraction of the extract led to the discovery of other compounds. The ellagitannin Lagerstroemin was identified as an effective component of the banaba extract responsible for the activity. In a different approach, using 3T3-L1 adipocytes as a cell model and a glucose uptake assay as the functional screening method, Chen et al. showed that the banaba water extract exhibited an insulin-like glucose transport inducing activity. Coupling HPLC fractionation with a glucose uptake assay, gallotannins were identified in the banaba extract as components responsible for the activity, not corosolic acid. Penta-O-galloyl-glucopyranose (PGG) was identified as the most potent gallotannin. A comparison of published data with results obtained for PGG indicates that PGG has a significantly higher glucose transport stimulatory activity than Lagerstroemin. Chen et al. have also shown that PGG exhibits anti-adipogenic properties in addition to stimulating the glucose uptake in adipocytes. The combination of glucose uptake and anti-adipogenesis activity is not found in the current insulin mimetic drugs and may indicate a great therapeutic potential of PGG.
原产于东南亚的假鹰爪属植物使君子(Lagerstroemia speciosa),通常被称为罗望子,其叶子以各种形式被菲律宾人传统地用于治疗糖尿病和肾脏相关疾病。20 世纪 90 年代,这种草药的普及开始引起全世界科学家的关注。从那时起,研究人员进行了大量的体外和体内研究,一致证实了罗望子的降血糖活性。科学家已经确定了罗望子的不同成分负责其活性。使用肿瘤细胞作为细胞模型,从罗望子甲醇提取物中分离出了熊果酸,并证明其为一种活性化合物。最近,使用不同的细胞模型和关注提取物的水溶性部分,发现了其他化合物。没食子鞣质 Lagerstroemin 被鉴定为负责提取物活性的有效成分。在另一种方法中,使用 3T3-L1 脂肪细胞作为细胞模型和葡萄糖摄取测定作为功能筛选方法,Chen 等人表明,罗望子水提取物表现出胰岛素样葡萄糖转运诱导活性。通过将 HPLC 分级与葡萄糖摄取测定相结合,在罗望子提取物中鉴定出鞣质作为负责该活性的成分,而不是熊果酸。五-O-没食子酰葡萄糖(PGG)被鉴定为最有效的鞣质。将已发表的数据与 PGG 获得的结果进行比较表明,PGG 具有比 Lagerstroemin 更高的葡萄糖转运刺激活性。Chen 等人还表明,PGG 除了刺激脂肪细胞摄取葡萄糖外,还具有抗脂肪生成特性。在目前的胰岛素模拟药物中未发现葡萄糖摄取和抗脂肪生成活性的组合,这可能表明 PGG 具有很大的治疗潜力。